Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in IBIO — iBio, Inc.

CIK 1214717 BOSTON, MA
Back to IBIO Full portfolio

Position in IBIO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$876,427
+$140,051 QoQ
Shares Held
500,816
+29.2% QoQ
Ownership
0.779%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 55 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. IBIO ranks #325 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in IBIO

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $876,427 500,816
2026-03-31 $736,376 387,567
2025-12-31 $429,637 222,610
2025-09-30 $125,586 151,309
2025-06-30 $85,348 112,301
2025-03-31 $412,487 102,609
2024-12-31 $205,302 83,797
2024-09-30 $122,148 55,022
2024-06-30 $103,805 49,197
2023-09-30 $33,790 112,636
2023-06-30 $46,533 76,285
2023-03-31 $158,672 76,285
2022-12-31 $33,565 76,285
2022-09-30 $343,631 2,021,363
2022-06-30 $525,554 2,021,363
2022-03-31 $1,548,966 3,602,247
2021-12-31 $2,074,360 3,771,565
2021-09-30 $4,347,027 4,100,969
2021-06-30 $5,394,754 3,572,685
2021-03-31 $5,159,848 3,350,551
2020-12-31 $2,594,298 2,470,760
2020-09-30 $3,041,642 1,498,346
2020-06-30 $1,560,102 702,749
2020-03-31 $344,289 324,801